Is Universal Health Services (UHS) a risky stock?
As of July 21, 2026, Clavix grades Universal Health Services (UHS) C- for risk, a composite score of 53 out of 100 on an A+ to F scale, which puts UHS in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind UHS's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how UHS scores on each, as of July 21, 2026.
What's moving UHS's risk right now
Company-specific signals Clavix flags behind UHS's current grade, drawn from recent news and filings as of July 21, 2026.
Guggenheim lowered its price target on UHS while maintaining a 'buy' rating, signaling ongoing confidence in the company alongside tempered near-term valuation expectations.
UHS traded lower as rising labor costs from the worsening nursing shortage and more uninsured patients threaten to pressure hospital profit margins.
UHS announced its regular dividend, signaling steady cash flow and financial health, though the payout is small compared to the stock price.
What a C- grade means
On the Clavix A+ to F scale, UHS's composite of 53 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell UHS or any security. Grades are risk indicators, not predictions of return. Data may be delayed.